Magnes, Teresa <br/><br/>
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.  [electronic resource] 

 -  PloS one  2017 
 - e0180995 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0180995  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>C-Reactive Protein--metabolism<br/>Carcinoma, Squamous Cell--diagnosis<br/>Cetuximab--therapeutic use<br/>Female<br/>Head and Neck Neoplasms--diagnosis<br/>Humans<br/>Leukocyte Count<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnosis<br/>Prognosis<br/>Research Design<br/>Retrospective Studies<br/>Squamous Cell Carcinoma of Head and Neck<br/>Survival Analysis<br/>Time Factors